FORTARO

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

calcifediol monohydrate, Quantity: 0.01 mg

Disponibbli minn:

DSM Nutritional Products Australia Pty Ltd

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; crospovidone; starch sodium octenyl succinate; sodium ascorbate; dl-alpha-tocopherol; sucrose; medium chain triglycerides

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Maintain/support general health and wellbeing ; Maintain/support healthy teeth ; Maintain/support bone health ; Aids/assists healthy bone development/growth/building ; Help maintain/support bone mineralisation ; Maintain/support heart health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support muscle health ; Maintain/support muscle function ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Maintain/support neuromuscular function ; Maintain/support nervous system health

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2020-11-27